Aptevo Therapeutics

APVO

Börsenwert 2,41 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Dimensional Fund Advisors Austin, Texas	6,74 Mio. $	–	–	–
2	2 Renaissance Technologies New York	5,74 Mio. $	–	–	–
3	3 Vanguard Group Malvern, Pennsylvania	3,66 Mio. $	–	–	–
4	4 Sessa Capital New York	2,59 Mio. $	–	–	–
5	5 Park West Asset Management San Francisco, California	2,5 Mio. $	–	–	–
6	6 Acadian Asset Management Boston, Massachusetts	1,83 Mio. $	–	–	–
7	7 BlackRock New York	1,75 Mio. $	–	–	–
8	8 D.E. Shaw & Co New York	1,58 Mio. $	–	–	–
9	9 JP Morgan Chase New York	1,45 Mio. $	–	–	–
10	10 HighVista Strategies Boston, Massachusetts	981.000 $	–	–	–
11	11 Oxford Asset Management Oxford, United Kingdom	874.000 $	–	–	–
12	12 Spark Investment Management New York	676.000 $	–	–	–
13	CL 13 CSS LLC Chicago, Illinois	592.000 $	–	–	–
14	14 Alambic Investment Management Belvedere, California	581.000 $	–	–	–
15	15 EAM Investors Solana Beach, California	552.000 $	–	–	–
16	16 Geode Capital Management Boston, Massachusetts	552.000 $	–	–	–
17	17 Bridgeway Capital Management Houston, Texas	469.000 $	–	–	–
18	18 Macquarie Group Sydney, NSW 2000, Australia	386.000 $	–	–	–
19	19 Man Group London, United Kingdom	380.000 $	–	–	–
20	20 Deutsche Bank Frankfurt Am Main Ge, Germany	363.000 $	–	–	–
21	21 Northern Trust Chicago, Illinois	352.000 $	–	–	–
22	22 Millennium Management New York	318.000 $	–	–	–
23	23 QS Investors New York	315.000 $	–	–	–
24	24 Atlas Capital Advisors Jackson, Wyoming	232.473 $	–	–	–
25	25 UBS Group Zurich, Switzerland	189.000 $	–	–	–

Aptevo Therapeutics APVO Börsenwert 2,41 Mio. $

Aptevo Therapeutics

APVO

Börsenwert 2,41 Mio. $